Fusion rate according to mixture ratio and volumes of bone graft in minimally invasive transforaminal lumbar interbody fusion: minimum 2-year follow-up
- PMID: 25217411
- DOI: 10.1007/s00590-014-1529-6
Fusion rate according to mixture ratio and volumes of bone graft in minimally invasive transforaminal lumbar interbody fusion: minimum 2-year follow-up
Abstract
Objectives: Hydroxyapatite (HA) is commonly used as bone substitute in clinical practices. However, only few studies have compared the relationship between the mixture ratio of bone graft in the actual clinical field and fusion rate according to bone graft volume. The study aimed to analyze the fusion rate according to the mixture ratio and the amount of bone graft in minimally invasive transforaminal lumbar interbody fusion (MI-TLIF).
Methods: A total number of 88 subjects who completed a 2-year follow-up after MI-TLIF participated in this study. Subjects were divided into three groups: Group 1 with local autograft, Group II with a mixture of HA and autobone of over 50%, and Group III with a mixture of HA and autobone of less than 50%. Subjects were also grouped into two groups: Group A with a graft volume of less than 12 ml and Group B with more than 12 ml. The correlation of mixture ratio and the graft volume with fusion rate was analyzed. For clinical analysis, visual analogue scale for pain and Oswestry Disability Index were used. Bone integration was evaluated based on the classification methods described in the Burkus study.
Results: Fusion rates are increased according to the ratio of autograft in all groups: 90.9% in Group I, 87.8% in Group II, and 85.7% in Group III. However, there were no significant differences between groups (p = 0.22). The fusion rates significantly increased as the amount of bone graft increased to over 12 ml, showing 81.5% in Group A and 92.0% in Group B (p = 0.03).
Conclusions: A high rate of fusion was achieved in MI-TLIF in graft volume of more than 12 ml. We therefore recommend at least 12 ml of bone graft volume for successful fusion.
Similar articles
-
Results of lumbar spondylodeses using different bone grafting materials after transforaminal lumbar interbody fusion (TLIF).Eur Spine J. 2017 Nov;26(11):2835-2842. doi: 10.1007/s00586-017-5145-0. Epub 2017 May 25. Eur Spine J. 2017. PMID: 28547573 Clinical Trial.
-
Dynamic stabilization for L4-5 spondylolisthesis: comparison with minimally invasive transforaminal lumbar interbody fusion with more than 2 years of follow-up.Neurosurg Focus. 2016 Jan;40(1):E3. doi: 10.3171/2015.10.FOCUS15441. Neurosurg Focus. 2016. PMID: 26721577
-
Clinical and radiographic outcomes using local bone shavings as autograft in minimally invasive transforaminal lumbar interbody fusion.World Neurosurg. 2012 Jul;78(1-2):185-90. doi: 10.1016/j.wneu.2011.05.049. Epub 2011 Nov 7. World Neurosurg. 2012. PMID: 22120378
-
Minimally Invasive Versus Traditional Open Transforaminal Lumbar Interbody Fusion for the Treatment of Single-Level Spondylolisthesis Grades 1 and 2: A Systematic Review and Meta-Analysis.World Neurosurg. 2019 Feb;122:180-189. doi: 10.1016/j.wneu.2018.10.202. Epub 2018 Nov 7. World Neurosurg. 2019. PMID: 30414524
-
Minimally invasive transforaminal lumbar interbody fusion versus open transforaminal lumbar interbody fusion: a technical description and review of the literature.Acta Neurochir (Wien). 2017 Jun;159(6):1137-1146. doi: 10.1007/s00701-017-3078-3. Epub 2017 Feb 3. Acta Neurochir (Wien). 2017. PMID: 28160064 Review.
Cited by
-
Direction-changeable cage reduces X-ray exposure in treating isthmic lumbar spondylolisthesis: a retrospective study.Am J Transl Res. 2019 Feb 15;11(2):1066-1072. eCollection 2019. Am J Transl Res. 2019. PMID: 30899406 Free PMC article.
-
Fusion's Location and Quality within the Fixated Segment Following Transforaminal Interbody Fusion (TLIF).Healthcare (Basel). 2023 Oct 24;11(21):2814. doi: 10.3390/healthcare11212814. Healthcare (Basel). 2023. PMID: 37957959 Free PMC article.
-
A novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery.BMC Surg. 2022 Oct 26;22(1):366. doi: 10.1186/s12893-022-01773-y. BMC Surg. 2022. PMID: 36289500 Free PMC article. Clinical Trial.
-
Ceramic Biologics for Bony Fusion-a Journey from First to Third Generations.Curr Rev Musculoskelet Med. 2020 Aug;13(4):530-536. doi: 10.1007/s12178-020-09651-x. Curr Rev Musculoskelet Med. 2020. PMID: 32562147 Free PMC article. Review.
-
Results of lumbar spondylodeses using different bone grafting materials after transforaminal lumbar interbody fusion (TLIF).Eur Spine J. 2017 Nov;26(11):2835-2842. doi: 10.1007/s00586-017-5145-0. Epub 2017 May 25. Eur Spine J. 2017. PMID: 28547573 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical